Your session is about to expire
← Back to Search
Combination Therapy for Cyclic Vomiting Syndrome
Study Summary
This trial will compare two drugs to see which is better at treating cyclic vomiting with fewer side effects.
- Cyclic Vomiting Syndrome
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Does this clinical trial admit participants who are in the senior age bracket?
"As per the guidelines listed for this trial, individuals aged 18 to 65 are eligible for enrollment."
Could you provide a synopsis of the other exploratory research conducted on haloperidol?
"Presently, there are 9 clinical trials in progress related to haloperidol. Of these studies, 3 have progressed into Phase 3 and are being conducted at 51 locations centered around Saint Joseph, Michigan."
What aims are being pursued in this clinical exploration?
"This trial is primarily tracking how well the treatment works to reduce nausea at two, twenty-four and forty-eight hours. Secondary endpoints of interest include the proportion of patients who are issued discharge orders in 2 hours, differences in abdominal pain scores relative to baseline at 1,2 24 and 48 hours, as well as assessing when rescue narcotics become necessary within the emergency department."
What clinical conditions is haloperidol frequently prescribed for?
"Haloperidol is often employed to assuage nausea, as well as address agitation, hyperactivity and hostile reactions."
What is the participant count for this experiment?
"Yes, the listings on clinicaltrials.gov confirm that this medical trial is recruiting participants as of October 25th 2022. It was initially posted August 30th 2021 and seeks to enrol 100 subjects across a single location."
What possible health risks are associated with the use of haloperidol?
"Haloperidol's safety is rated a 2 on the scale, as there exists some evidence of its security but no proof for effectiveness in this Phase 2 trial."
Who qualifies to join this medical experiment?
"To be eligible for this research, individuals must have experienced vomiting and lie within the age group of 18 - 65. The trial is seeking to enrol approximately one hundred participants in total."
Are additional participants being sought for this experiment?
"According to clinicaltrials.gov, the recruitment of patients for this medical trial is still ongoing since it was first made available on August 30th 2021 and updated lastly in October 25th 2022."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Share this study with friends
Copy Link
Messenger